nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC22A3—Vincristine—muscle cancer	0.171	0.233	CbGbCtD
Imipramine—CYP2E1—Dacarbazine—muscle cancer	0.0996	0.136	CbGbCtD
Imipramine—CYP1A2—Dacarbazine—muscle cancer	0.0576	0.0786	CbGbCtD
Imipramine—CYP3A7—Vincristine—muscle cancer	0.0551	0.0752	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0551	0.0752	CbGbCtD
Imipramine—CYP2E1—Etoposide—muscle cancer	0.0487	0.0665	CbGbCtD
Imipramine—ABCB1—Dactinomycin—muscle cancer	0.0437	0.0596	CbGbCtD
Imipramine—CYP2B6—Doxorubicin—muscle cancer	0.0328	0.0447	CbGbCtD
Imipramine—CYP1A2—Etoposide—muscle cancer	0.0282	0.0385	CbGbCtD
Imipramine—ABCB1—Vincristine—muscle cancer	0.0269	0.0367	CbGbCtD
Imipramine—ABCB1—Etoposide—muscle cancer	0.0247	0.0336	CbGbCtD
Imipramine—ABCB1—Doxorubicin—muscle cancer	0.0168	0.0229	CbGbCtD
Imipramine—ABCB1—Methotrexate—muscle cancer	0.0163	0.0222	CbGbCtD
Imipramine—CYP3A4—Vincristine—muscle cancer	0.0161	0.022	CbGbCtD
Imipramine—CYP2D6—Doxorubicin—muscle cancer	0.0158	0.0216	CbGbCtD
Imipramine—CYP3A4—Etoposide—muscle cancer	0.0148	0.0201	CbGbCtD
Imipramine—CYP3A4—Doxorubicin—muscle cancer	0.0101	0.0137	CbGbCtD
Imipramine—CHRM3—muscle of abdomen—muscle cancer	0.00917	0.0949	CbGeAlD
Imipramine—SLC22A4—larynx—muscle cancer	0.00766	0.0793	CbGeAlD
Imipramine—HTR2A—hindlimb—muscle cancer	0.00279	0.0289	CbGeAlD
Imipramine—HTR2A—appendage—muscle cancer	0.00239	0.0248	CbGeAlD
Imipramine—KCND3—cardiac atrium—muscle cancer	0.00218	0.0226	CbGeAlD
Imipramine—KCND2—head—muscle cancer	0.00187	0.0193	CbGeAlD
Imipramine—KCND2—testis—muscle cancer	0.0018	0.0187	CbGeAlD
Imipramine—SLC22A2—renal system—muscle cancer	0.00173	0.0179	CbGeAlD
Imipramine—ADRA1B—renal system—muscle cancer	0.00165	0.0171	CbGeAlD
Imipramine—KCND3—head—muscle cancer	0.00163	0.0168	CbGeAlD
Imipramine—CYP2C18—vagina—muscle cancer	0.0016	0.0166	CbGeAlD
Imipramine—KCND3—testis—muscle cancer	0.00157	0.0163	CbGeAlD
Imipramine—CHRM4—head—muscle cancer	0.00155	0.016	CbGeAlD
Imipramine—SLC22A3—embryo—muscle cancer	0.00154	0.016	CbGeAlD
Imipramine—CHRM4—testis—muscle cancer	0.0015	0.0155	CbGeAlD
Imipramine—HTR6—head—muscle cancer	0.00139	0.0144	CbGeAlD
Imipramine—SLC22A4—renal system—muscle cancer	0.00128	0.0133	CbGeAlD
Imipramine—SLC22A1—renal system—muscle cancer	0.00122	0.0126	CbGeAlD
Imipramine—SLC22A3—smooth muscle tissue—muscle cancer	0.00121	0.0126	CbGeAlD
Imipramine—CHRM5—head—muscle cancer	0.00121	0.0125	CbGeAlD
Imipramine—SLC22A3—renal system—muscle cancer	0.00117	0.0121	CbGeAlD
Imipramine—ADRA1B—head—muscle cancer	0.00111	0.0115	CbGeAlD
Imipramine—ADRA1D—head—muscle cancer	0.00108	0.0112	CbGeAlD
Imipramine—CHRM3—smooth muscle tissue—muscle cancer	0.00105	0.0109	CbGeAlD
Imipramine—CHRM3—renal system—muscle cancer	0.00101	0.0105	CbGeAlD
Imipramine—HTR1A—renal system—muscle cancer	0.00101	0.0104	CbGeAlD
Imipramine—ORM1—bone marrow—muscle cancer	0.00101	0.0104	CbGeAlD
Imipramine—HTR7—smooth muscle tissue—muscle cancer	0.001	0.0104	CbGeAlD
Imipramine—SLC22A4—tendon—muscle cancer	0.001	0.0104	CbGeAlD
Imipramine—SLC22A4—bone marrow—muscle cancer	0.000969	0.01	CbGeAlD
Imipramine—HTR7—renal system—muscle cancer	0.000964	0.00998	CbGeAlD
Imipramine—ADRA1A—renal system—muscle cancer	0.00093	0.00962	CbGeAlD
Imipramine—SLC22A4—vagina—muscle cancer	0.000929	0.00962	CbGeAlD
Imipramine—KCNH2—renal system—muscle cancer	0.000898	0.0093	CbGeAlD
Imipramine—SLC22A1—vagina—muscle cancer	0.000884	0.00916	CbGeAlD
Imipramine—SLC22A3—vagina—muscle cancer	0.000845	0.00875	CbGeAlD
Imipramine—CHRM2—head—muscle cancer	0.000832	0.00861	CbGeAlD
Imipramine—SLC6A3—head—muscle cancer	0.000829	0.00859	CbGeAlD
Imipramine—SLC22A1—head—muscle cancer	0.000817	0.00846	CbGeAlD
Imipramine—KCNH2—cardiac atrium—muscle cancer	0.000804	0.00832	CbGeAlD
Imipramine—HTR2C—head—muscle cancer	0.000802	0.0083	CbGeAlD
Imipramine—SLC6A3—testis—muscle cancer	0.000801	0.00829	CbGeAlD
Imipramine—HTR2A—embryo—muscle cancer	0.000794	0.00822	CbGeAlD
Imipramine—SLC22A3—head—muscle cancer	0.000781	0.00808	CbGeAlD
Imipramine—CYP1A2—renal system—muscle cancer	0.000769	0.00796	CbGeAlD
Imipramine—SLC6A4—head—muscle cancer	0.00076	0.00787	CbGeAlD
Imipramine—CHRM1—head—muscle cancer	0.000757	0.00784	CbGeAlD
Imipramine—SLC22A3—testis—muscle cancer	0.000754	0.00781	CbGeAlD
Imipramine—HTR7—tendon—muscle cancer	0.000752	0.00779	CbGeAlD
Imipramine—HRH1—smooth muscle tissue—muscle cancer	0.000747	0.00774	CbGeAlD
Imipramine—CYP2B6—renal system—muscle cancer	0.000737	0.00763	CbGeAlD
Imipramine—CYP2E1—renal system—muscle cancer	0.000691	0.00716	CbGeAlD
Imipramine—CYP2C19—vagina—muscle cancer	0.000682	0.00706	CbGeAlD
Imipramine—KCNH2—bone marrow—muscle cancer	0.000679	0.00703	CbGeAlD
Imipramine—Coordination abnormal—Doxorubicin—muscle cancer	0.000678	0.00398	CcSEcCtD
Imipramine—CHRM3—head—muscle cancer	0.000677	0.00701	CbGeAlD
Imipramine—HTR1A—head—muscle cancer	0.000675	0.00699	CbGeAlD
Imipramine—Agranulocytosis—Etoposide—muscle cancer	0.00067	0.00394	CcSEcCtD
Imipramine—SLC6A2—head—muscle cancer	0.000669	0.00693	CbGeAlD
Imipramine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000666	0.00391	CcSEcCtD
Imipramine—CHRM3—testis—muscle cancer	0.000654	0.00678	CbGeAlD
Imipramine—Discomfort—Dactinomycin—muscle cancer	0.000652	0.00383	CcSEcCtD
Imipramine—KCNH2—vagina—muscle cancer	0.00065	0.00673	CbGeAlD
Imipramine—SLC6A2—testis—muscle cancer	0.000646	0.00669	CbGeAlD
Imipramine—HTR7—head—muscle cancer	0.000645	0.00668	CbGeAlD
Imipramine—Hypoaesthesia—Etoposide—muscle cancer	0.000641	0.00377	CcSEcCtD
Imipramine—Urinary tract disorder—Etoposide—muscle cancer	0.000637	0.00374	CcSEcCtD
Imipramine—Agitation—Vincristine—muscle cancer	0.000637	0.00374	CcSEcCtD
Imipramine—Oedema—Dactinomycin—muscle cancer	0.000633	0.00372	CcSEcCtD
Imipramine—Urethral disorder—Etoposide—muscle cancer	0.000632	0.00371	CcSEcCtD
Imipramine—Infection—Dactinomycin—muscle cancer	0.000629	0.00369	CcSEcCtD
Imipramine—HTR2A—smooth muscle tissue—muscle cancer	0.000624	0.00646	CbGeAlD
Imipramine—HTR7—testis—muscle cancer	0.000623	0.00645	CbGeAlD
Imipramine—ADRA1A—head—muscle cancer	0.000622	0.00644	CbGeAlD
Imipramine—Leukopenia—Vincristine—muscle cancer	0.00062	0.00364	CcSEcCtD
Imipramine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00062	0.00364	CcSEcCtD
Imipramine—DRD2—head—muscle cancer	0.00061	0.00631	CbGeAlD
Imipramine—Anorexia—Dactinomycin—muscle cancer	0.000603	0.00354	CcSEcCtD
Imipramine—Eye disorder—Etoposide—muscle cancer	0.000603	0.00354	CcSEcCtD
Imipramine—HTR2A—renal system—muscle cancer	0.000601	0.00622	CbGeAlD
Imipramine—KCNH2—head—muscle cancer	0.000601	0.00622	CbGeAlD
Imipramine—Convulsion—Vincristine—muscle cancer	0.0006	0.00352	CcSEcCtD
Imipramine—Flushing—Etoposide—muscle cancer	0.000598	0.00351	CcSEcCtD
Imipramine—Cardiac disorder—Etoposide—muscle cancer	0.000598	0.00351	CcSEcCtD
Imipramine—Hypertension—Vincristine—muscle cancer	0.000598	0.00351	CcSEcCtD
Imipramine—DRD2—testis—muscle cancer	0.000589	0.0061	CbGeAlD
Imipramine—Angiopathy—Etoposide—muscle cancer	0.000585	0.00343	CcSEcCtD
Imipramine—Immune system disorder—Etoposide—muscle cancer	0.000582	0.00342	CcSEcCtD
Imipramine—Mediastinal disorder—Etoposide—muscle cancer	0.000581	0.00341	CcSEcCtD
Imipramine—KCNH2—testis—muscle cancer	0.00058	0.00601	CbGeAlD
Imipramine—Alopecia—Etoposide—muscle cancer	0.00057	0.00335	CcSEcCtD
Imipramine—Cerebrovascular accident—Methotrexate—muscle cancer	0.00057	0.00334	CcSEcCtD
Imipramine—Oedema—Vincristine—muscle cancer	0.000565	0.00332	CcSEcCtD
Imipramine—Anaphylactic shock—Vincristine—muscle cancer	0.000565	0.00332	CcSEcCtD
Imipramine—Infection—Vincristine—muscle cancer	0.000562	0.0033	CcSEcCtD
Imipramine—HRH1—tendon—muscle cancer	0.000562	0.00582	CbGeAlD
Imipramine—CYP3A4—renal system—muscle cancer	0.000556	0.00576	CbGeAlD
Imipramine—Nervous system disorder—Vincristine—muscle cancer	0.000555	0.00326	CcSEcCtD
Imipramine—Thrombocytopenia—Vincristine—muscle cancer	0.000554	0.00325	CcSEcCtD
Imipramine—Decreased appetite—Dactinomycin—muscle cancer	0.00055	0.00323	CcSEcCtD
Imipramine—Dysgeusia—Etoposide—muscle cancer	0.00055	0.00323	CcSEcCtD
Imipramine—CYP2D6—renal system—muscle cancer	0.000547	0.00567	CbGeAlD
Imipramine—Hyperhidrosis—Vincristine—muscle cancer	0.000547	0.00321	CcSEcCtD
Imipramine—Fatigue—Dactinomycin—muscle cancer	0.000546	0.0032	CcSEcCtD
Imipramine—Vascular purpura—Doxorubicin—muscle cancer	0.00054	0.00317	CcSEcCtD
Imipramine—CYP2E1—tendon—muscle cancer	0.00054	0.00559	CbGeAlD
Imipramine—Anorexia—Vincristine—muscle cancer	0.000539	0.00316	CcSEcCtD
Imipramine—CYP2B6—vagina—muscle cancer	0.000534	0.00553	CbGeAlD
Imipramine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000533	0.00313	CcSEcCtD
Imipramine—Mood swings—Methotrexate—muscle cancer	0.000529	0.0031	CcSEcCtD
Imipramine—Ataxia—Methotrexate—muscle cancer	0.000525	0.00308	CcSEcCtD
Imipramine—Feeling abnormal—Dactinomycin—muscle cancer	0.000522	0.00306	CcSEcCtD
Imipramine—HRH1—vagina—muscle cancer	0.000521	0.0054	CbGeAlD
Imipramine—Ill-defined disorder—Etoposide—muscle cancer	0.000521	0.00306	CcSEcCtD
Imipramine—ABCB1—embryo—muscle cancer	0.00052	0.00539	CbGeAlD
Imipramine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000518	0.00304	CcSEcCtD
Imipramine—Hot flush—Doxorubicin—muscle cancer	0.000517	0.00303	CcSEcCtD
Imipramine—Liver function test abnormal—Methotrexate—muscle cancer	0.000515	0.00303	CcSEcCtD
Imipramine—Menopausal symptoms—Doxorubicin—muscle cancer	0.000512	0.00301	CcSEcCtD
Imipramine—Insomnia—Vincristine—muscle cancer	0.000511	0.003	CcSEcCtD
Imipramine—Paraesthesia—Vincristine—muscle cancer	0.000508	0.00298	CcSEcCtD
Imipramine—Malaise—Etoposide—muscle cancer	0.000506	0.00297	CcSEcCtD
Imipramine—Breast disorder—Methotrexate—muscle cancer	0.000504	0.00296	CcSEcCtD
Imipramine—Leukopenia—Etoposide—muscle cancer	0.000502	0.00295	CcSEcCtD
Imipramine—Purpura—Doxorubicin—muscle cancer	0.000502	0.00294	CcSEcCtD
Imipramine—Body temperature increased—Dactinomycin—muscle cancer	0.0005	0.00294	CcSEcCtD
Imipramine—Abdominal pain—Dactinomycin—muscle cancer	0.0005	0.00294	CcSEcCtD
Imipramine—Cardiac failure—Doxorubicin—muscle cancer	0.000495	0.00291	CcSEcCtD
Imipramine—Loss of consciousness—Etoposide—muscle cancer	0.000493	0.0029	CcSEcCtD
Imipramine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000493	0.0029	CcSEcCtD
Imipramine—CYP2B6—head—muscle cancer	0.000493	0.0051	CbGeAlD
Imipramine—Decreased appetite—Vincristine—muscle cancer	0.000492	0.00289	CcSEcCtD
Imipramine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000488	0.00287	CcSEcCtD
Imipramine—Fatigue—Vincristine—muscle cancer	0.000487	0.00286	CcSEcCtD
Imipramine—Convulsion—Etoposide—muscle cancer	0.000486	0.00286	CcSEcCtD
Imipramine—Hypertension—Etoposide—muscle cancer	0.000485	0.00285	CcSEcCtD
Imipramine—Constipation—Vincristine—muscle cancer	0.000484	0.00284	CcSEcCtD
Imipramine—HRH1—head—muscle cancer	0.000481	0.00498	CbGeAlD
Imipramine—Eosinophilia—Methotrexate—muscle cancer	0.000478	0.0028	CcSEcCtD
Imipramine—CYP2B6—testis—muscle cancer	0.000476	0.00493	CbGeAlD
Imipramine—Affect lability—Doxorubicin—muscle cancer	0.000476	0.00279	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000475	0.00279	CcSEcCtD
Imipramine—Discomfort—Etoposide—muscle cancer	0.000472	0.00277	CcSEcCtD
Imipramine—HTR2A—tendon—muscle cancer	0.000469	0.00486	CbGeAlD
Imipramine—HRH1—testis—muscle cancer	0.000465	0.00482	CbGeAlD
Imipramine—CYP2E1—head—muscle cancer	0.000463	0.00479	CbGeAlD
Imipramine—Gastrointestinal pain—Vincristine—muscle cancer	0.000462	0.00271	CcSEcCtD
Imipramine—Confusional state—Etoposide—muscle cancer	0.000462	0.00271	CcSEcCtD
Imipramine—Pancytopenia—Methotrexate—muscle cancer	0.000458	0.00269	CcSEcCtD
Imipramine—Anaphylactic shock—Etoposide—muscle cancer	0.000458	0.00269	CcSEcCtD
Imipramine—Mood swings—Doxorubicin—muscle cancer	0.000458	0.00269	CcSEcCtD
Imipramine—Infection—Etoposide—muscle cancer	0.000455	0.00267	CcSEcCtD
Imipramine—Ataxia—Doxorubicin—muscle cancer	0.000455	0.00267	CcSEcCtD
Imipramine—Asthenia—Dactinomycin—muscle cancer	0.000454	0.00267	CcSEcCtD
Imipramine—Thrombocytopenia—Etoposide—muscle cancer	0.000448	0.00263	CcSEcCtD
Imipramine—Tachycardia—Etoposide—muscle cancer	0.000447	0.00262	CcSEcCtD
Imipramine—Body temperature increased—Vincristine—muscle cancer	0.000447	0.00262	CcSEcCtD
Imipramine—Abdominal pain—Vincristine—muscle cancer	0.000447	0.00262	CcSEcCtD
Imipramine—CYP2E1—testis—muscle cancer	0.000447	0.00463	CbGeAlD
Imipramine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000446	0.00262	CcSEcCtD
Imipramine—Skin disorder—Etoposide—muscle cancer	0.000445	0.00261	CcSEcCtD
Imipramine—Erectile dysfunction—Methotrexate—muscle cancer	0.000444	0.00261	CcSEcCtD
Imipramine—Hyperhidrosis—Etoposide—muscle cancer	0.000443	0.0026	CcSEcCtD
Imipramine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000441	0.00259	CcSEcCtD
Imipramine—Photosensitivity reaction—Methotrexate—muscle cancer	0.00044	0.00259	CcSEcCtD
Imipramine—Breast disorder—Doxorubicin—muscle cancer	0.000437	0.00256	CcSEcCtD
Imipramine—Anorexia—Etoposide—muscle cancer	0.000437	0.00256	CcSEcCtD
Imipramine—HTR2A—vagina—muscle cancer	0.000435	0.00451	CbGeAlD
Imipramine—Diarrhoea—Dactinomycin—muscle cancer	0.000433	0.00254	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—muscle cancer	0.00043	0.00253	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—muscle cancer	0.00043	0.00253	CcSEcCtD
Imipramine—Infestation—Methotrexate—muscle cancer	0.00043	0.00253	CcSEcCtD
Imipramine—Stomatitis—Methotrexate—muscle cancer	0.000419	0.00246	CcSEcCtD
Imipramine—Eosinophilia—Doxorubicin—muscle cancer	0.000414	0.00243	CcSEcCtD
Imipramine—Paraesthesia—Etoposide—muscle cancer	0.000411	0.00241	CcSEcCtD
Imipramine—Somnolence—Etoposide—muscle cancer	0.000407	0.00239	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000407	0.00239	CcSEcCtD
Imipramine—Asthenia—Vincristine—muscle cancer	0.000406	0.00238	CcSEcCtD
Imipramine—Vomiting—Dactinomycin—muscle cancer	0.000402	0.00236	CcSEcCtD
Imipramine—HTR2A—head—muscle cancer	0.000402	0.00416	CbGeAlD
Imipramine—Agranulocytosis—Methotrexate—muscle cancer	0.000401	0.00236	CcSEcCtD
Imipramine—Rash—Dactinomycin—muscle cancer	0.000399	0.00234	CcSEcCtD
Imipramine—Decreased appetite—Etoposide—muscle cancer	0.000398	0.00234	CcSEcCtD
Imipramine—Pancytopenia—Doxorubicin—muscle cancer	0.000397	0.00233	CcSEcCtD
Imipramine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000395	0.00232	CcSEcCtD
Imipramine—Fatigue—Etoposide—muscle cancer	0.000395	0.00232	CcSEcCtD
Imipramine—ABCB1—renal system—muscle cancer	0.000394	0.00408	CbGeAlD
Imipramine—Constipation—Etoposide—muscle cancer	0.000392	0.0023	CcSEcCtD
Imipramine—HTR2A—testis—muscle cancer	0.000388	0.00402	CbGeAlD
Imipramine—Diarrhoea—Vincristine—muscle cancer	0.000387	0.00227	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—muscle cancer	0.000386	0.00227	CcSEcCtD
Imipramine—Pollakiuria—Doxorubicin—muscle cancer	0.000386	0.00227	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—muscle cancer	0.000381	0.00224	CcSEcCtD
Imipramine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000381	0.00224	CcSEcCtD
Imipramine—Weight increased—Doxorubicin—muscle cancer	0.00038	0.00223	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—muscle cancer	0.000379	0.00222	CcSEcCtD
Imipramine—Weight decreased—Doxorubicin—muscle cancer	0.000378	0.00222	CcSEcCtD
Imipramine—Feeling abnormal—Etoposide—muscle cancer	0.000377	0.00222	CcSEcCtD
Imipramine—Nausea—Dactinomycin—muscle cancer	0.000376	0.00221	CcSEcCtD
Imipramine—Gastrointestinal pain—Etoposide—muscle cancer	0.000375	0.0022	CcSEcCtD
Imipramine—Dizziness—Vincristine—muscle cancer	0.000374	0.0022	CcSEcCtD
Imipramine—Drowsiness—Doxorubicin—muscle cancer	0.000372	0.00219	CcSEcCtD
Imipramine—Infestation NOS—Doxorubicin—muscle cancer	0.000372	0.00219	CcSEcCtD
Imipramine—Infestation—Doxorubicin—muscle cancer	0.000372	0.00219	CcSEcCtD
Imipramine—CYP2D6—head—muscle cancer	0.000366	0.00379	CbGeAlD
Imipramine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000365	0.00214	CcSEcCtD
Imipramine—Urticaria—Etoposide—muscle cancer	0.000364	0.00214	CcSEcCtD
Imipramine—Jaundice—Doxorubicin—muscle cancer	0.000363	0.00213	CcSEcCtD
Imipramine—Stomatitis—Doxorubicin—muscle cancer	0.000363	0.00213	CcSEcCtD
Imipramine—Abdominal pain—Etoposide—muscle cancer	0.000362	0.00213	CcSEcCtD
Imipramine—Body temperature increased—Etoposide—muscle cancer	0.000362	0.00213	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—muscle cancer	0.000361	0.00212	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—muscle cancer	0.00036	0.00211	CcSEcCtD
Imipramine—Vomiting—Vincristine—muscle cancer	0.00036	0.00211	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—muscle cancer	0.000358	0.0021	CcSEcCtD
Imipramine—Rash—Vincristine—muscle cancer	0.000357	0.00209	CcSEcCtD
Imipramine—Dermatitis—Vincristine—muscle cancer	0.000356	0.00209	CcSEcCtD
Imipramine—Headache—Vincristine—muscle cancer	0.000354	0.00208	CcSEcCtD
Imipramine—CYP2D6—testis—muscle cancer	0.000354	0.00366	CbGeAlD
Imipramine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000352	0.00207	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—muscle cancer	0.00035	0.00206	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—muscle cancer	0.000349	0.00205	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—muscle cancer	0.000348	0.00204	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—muscle cancer	0.000348	0.00204	CcSEcCtD
Imipramine—Alopecia—Methotrexate—muscle cancer	0.000341	0.002	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—muscle cancer	0.000338	0.00199	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—muscle cancer	0.000336	0.00197	CcSEcCtD
Imipramine—Nausea—Vincristine—muscle cancer	0.000336	0.00197	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—muscle cancer	0.000334	0.00196	CcSEcCtD
Imipramine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000333	0.00195	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00033	0.00194	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—muscle cancer	0.000329	0.00193	CcSEcCtD
Imipramine—Asthenia—Etoposide—muscle cancer	0.000329	0.00193	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—muscle cancer	0.000328	0.00192	CcSEcCtD
Imipramine—Pruritus—Etoposide—muscle cancer	0.000324	0.0019	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—muscle cancer	0.000317	0.00186	CcSEcCtD
Imipramine—Diarrhoea—Etoposide—muscle cancer	0.000313	0.00184	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—muscle cancer	0.000312	0.00183	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—muscle cancer	0.000312	0.00183	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—muscle cancer	0.000312	0.00183	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—muscle cancer	0.00031	0.00182	CcSEcCtD
Imipramine—Flushing—Doxorubicin—muscle cancer	0.00031	0.00182	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—muscle cancer	0.000303	0.00178	CcSEcCtD
Imipramine—Malaise—Methotrexate—muscle cancer	0.000303	0.00178	CcSEcCtD
Imipramine—Dizziness—Etoposide—muscle cancer	0.000303	0.00178	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—muscle cancer	0.000302	0.00177	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000301	0.00177	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—muscle cancer	0.000301	0.00177	CcSEcCtD
Imipramine—Arrhythmia—Doxorubicin—muscle cancer	0.000299	0.00175	CcSEcCtD
Imipramine—ABCB1—bone marrow—muscle cancer	0.000298	0.00308	CbGeAlD
Imipramine—Alopecia—Doxorubicin—muscle cancer	0.000295	0.00173	CcSEcCtD
Imipramine—Mental disorder—Doxorubicin—muscle cancer	0.000293	0.00172	CcSEcCtD
Imipramine—Convulsion—Methotrexate—muscle cancer	0.000291	0.00171	CcSEcCtD
Imipramine—Vomiting—Etoposide—muscle cancer	0.000291	0.00171	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—muscle cancer	0.000291	0.00171	CcSEcCtD
Imipramine—Rash—Etoposide—muscle cancer	0.000289	0.0017	CcSEcCtD
Imipramine—Dermatitis—Etoposide—muscle cancer	0.000289	0.00169	CcSEcCtD
Imipramine—Headache—Etoposide—muscle cancer	0.000287	0.00168	CcSEcCtD
Imipramine—Tension—Doxorubicin—muscle cancer	0.000286	0.00168	CcSEcCtD
Imipramine—ABCB1—vagina—muscle cancer	0.000285	0.00295	CbGeAlD
Imipramine—Dysgeusia—Doxorubicin—muscle cancer	0.000285	0.00167	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000284	0.00167	CcSEcCtD
Imipramine—Discomfort—Methotrexate—muscle cancer	0.000283	0.00166	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—muscle cancer	0.000283	0.00166	CcSEcCtD
Imipramine—Confusional state—Methotrexate—muscle cancer	0.000277	0.00162	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—muscle cancer	0.000274	0.00161	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—muscle cancer	0.000274	0.00161	CcSEcCtD
Imipramine—Infection—Methotrexate—muscle cancer	0.000273	0.0016	CcSEcCtD
Imipramine—Nausea—Etoposide—muscle cancer	0.000272	0.0016	CcSEcCtD
Imipramine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00027	0.00159	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—muscle cancer	0.000269	0.00158	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—muscle cancer	0.000269	0.00158	CcSEcCtD
Imipramine—Agitation—Doxorubicin—muscle cancer	0.000268	0.00157	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—muscle cancer	0.000266	0.00156	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—muscle cancer	0.000265	0.00156	CcSEcCtD
Imipramine—ABCB1—head—muscle cancer	0.000263	0.00273	CbGeAlD
Imipramine—Malaise—Doxorubicin—muscle cancer	0.000263	0.00154	CcSEcCtD
Imipramine—Anorexia—Methotrexate—muscle cancer	0.000262	0.00154	CcSEcCtD
Imipramine—Syncope—Doxorubicin—muscle cancer	0.000261	0.00153	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—muscle cancer	0.000261	0.00153	CcSEcCtD
Imipramine—Palpitations—Doxorubicin—muscle cancer	0.000257	0.00151	CcSEcCtD
Imipramine—Loss of consciousness—Doxorubicin—muscle cancer	0.000256	0.0015	CcSEcCtD
Imipramine—ABCB1—testis—muscle cancer	0.000255	0.00264	CbGeAlD
Imipramine—Convulsion—Doxorubicin—muscle cancer	0.000252	0.00148	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—muscle cancer	0.000251	0.00148	CcSEcCtD
Imipramine—Insomnia—Methotrexate—muscle cancer	0.000248	0.00146	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—muscle cancer	0.000247	0.00145	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—muscle cancer	0.000246	0.00145	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000246	0.00145	CcSEcCtD
Imipramine—Discomfort—Doxorubicin—muscle cancer	0.000245	0.00144	CcSEcCtD
Imipramine—Somnolence—Methotrexate—muscle cancer	0.000244	0.00143	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—muscle cancer	0.000242	0.00142	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—muscle cancer	0.000242	0.00142	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—muscle cancer	0.00024	0.00141	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—muscle cancer	0.000239	0.0014	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000238	0.00139	CcSEcCtD
Imipramine—Oedema—Doxorubicin—muscle cancer	0.000238	0.00139	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000237	0.00139	CcSEcCtD
Imipramine—Fatigue—Methotrexate—muscle cancer	0.000237	0.00139	CcSEcCtD
Imipramine—Infection—Doxorubicin—muscle cancer	0.000236	0.00139	CcSEcCtD
Imipramine—Shock—Doxorubicin—muscle cancer	0.000234	0.00137	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—muscle cancer	0.000233	0.00137	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000233	0.00137	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—muscle cancer	0.000232	0.00136	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—muscle cancer	0.000231	0.00135	CcSEcCtD
Imipramine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00023	0.00135	CcSEcCtD
Imipramine—Anorexia—Doxorubicin—muscle cancer	0.000226	0.00133	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—muscle cancer	0.000226	0.00133	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000224	0.00132	CcSEcCtD
Imipramine—Urticaria—Methotrexate—muscle cancer	0.000218	0.00128	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—muscle cancer	0.000217	0.00127	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—muscle cancer	0.000217	0.00127	CcSEcCtD
Imipramine—Insomnia—Doxorubicin—muscle cancer	0.000215	0.00126	CcSEcCtD
Imipramine—Paraesthesia—Doxorubicin—muscle cancer	0.000213	0.00125	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—muscle cancer	0.000211	0.00124	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—muscle cancer	0.000209	0.00123	CcSEcCtD
Imipramine—Decreased appetite—Doxorubicin—muscle cancer	0.000207	0.00121	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000205	0.0012	CcSEcCtD
Imipramine—Fatigue—Doxorubicin—muscle cancer	0.000205	0.0012	CcSEcCtD
Imipramine—Constipation—Doxorubicin—muscle cancer	0.000203	0.00119	CcSEcCtD
Imipramine—Asthenia—Methotrexate—muscle cancer	0.000197	0.00116	CcSEcCtD
Imipramine—Feeling abnormal—Doxorubicin—muscle cancer	0.000196	0.00115	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000194	0.00114	CcSEcCtD
Imipramine—Pruritus—Methotrexate—muscle cancer	0.000194	0.00114	CcSEcCtD
Imipramine—Urticaria—Doxorubicin—muscle cancer	0.000189	0.00111	CcSEcCtD
Imipramine—Body temperature increased—Doxorubicin—muscle cancer	0.000188	0.0011	CcSEcCtD
Imipramine—Abdominal pain—Doxorubicin—muscle cancer	0.000188	0.0011	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—muscle cancer	0.000188	0.0011	CcSEcCtD
Imipramine—Dizziness—Methotrexate—muscle cancer	0.000181	0.00107	CcSEcCtD
Imipramine—Vomiting—Methotrexate—muscle cancer	0.000174	0.00102	CcSEcCtD
Imipramine—Rash—Methotrexate—muscle cancer	0.000173	0.00102	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—muscle cancer	0.000173	0.00101	CcSEcCtD
Imipramine—Headache—Methotrexate—muscle cancer	0.000172	0.00101	CcSEcCtD
Imipramine—Asthenia—Doxorubicin—muscle cancer	0.00017	0.001	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—muscle cancer	0.000168	0.000987	CcSEcCtD
Imipramine—Nausea—Methotrexate—muscle cancer	0.000163	0.000957	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—muscle cancer	0.000163	0.000954	CcSEcCtD
Imipramine—Dizziness—Doxorubicin—muscle cancer	0.000157	0.000922	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—muscle cancer	0.000151	0.000887	CcSEcCtD
Imipramine—Rash—Doxorubicin—muscle cancer	0.00015	0.000879	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—muscle cancer	0.00015	0.000879	CcSEcCtD
Imipramine—Headache—Doxorubicin—muscle cancer	0.000149	0.000874	CcSEcCtD
Imipramine—Nausea—Doxorubicin—muscle cancer	0.000141	0.000829	CcSEcCtD
